OKYO Pharma (OKYO) Short term Debt (2023 - 2025)

OKYO Pharma (OKYO) has 3 years of Short term Debt data on file, last reported at $185795.0 in Q3 2025.

• Short term Debt for Q3 2025 came in at $185795.0, up 10176.27% year-over-year; the trailing twelve-month figure through Sep 2025 was $185795.0 (up 10176.27% YoY), and the FY2025 annual result was $859325.0, up 139.56% from the prior year.
• Short term Debt slipped to $185795.0 in Q3 2025 per OKYO's latest filing, from $859325.0 in the prior quarter.
• Over five years, Short term Debt peaked at $859325.0 in Q1 2025 and troughed at $1808.0 in Q3 2024.
• A 3-year average of $384836.6 and a median of $358709.0 in 2024 frame the typical range for Short term Debt.
• The sharpest annual moves came in 2024 and 2025: Short term Debt sank 99.65% in 2024, then soared 10176.27% in 2025.
• A 3-year view of Short term Debt shows it stood at $518546.0 in 2023, then slumped by 99.65% to $1808.0 in 2024, then soared by 10176.27% to $185795.0 in 2025.
• Business Quant data shows OKYO's Short term Debt at $185795.0 in Q3 2025, $859325.0 in Q1 2025, and $1808.0 in Q3 2024.